Dentons represented Xenocor in the transaction. Xenocor, Inc. closed its Series A-2 Financing with its lead investor, GenHenn Capital Venture Fund I. Xenocor growth and mission...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here